title: EMA revokes marketing authorization for bufexamac.
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Uter
authors.forename: Axel
authors.initials: A
authors.lastname: Schnuch
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002019:Bufexamac / Q000009:adverse effects*; D003659:Decision Making, Organizational; D005060:Europe; D005062:European Union / Q000458:organization & administration; D006077:Government Agencies; D006801:Humans; D040541:Marketing; D056737:Safety-Based Drug Withdrawals
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D002019:Bufexamac